CCN2 Enhances Resistance to Cisplatin-Mediating Cell Apoptosis in Human Osteosarcoma

Osteosarcoma (OS) is the most common form of malignant bone tumor and is an aggressive malignant neoplasm exhibiting osteoblastic differentiation. Cisplatin is one of the most efficacious antitumor drugs for osteosarcoma patients. However, treatment failures are common due to the development of chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hsiao-Chi, Huang, Chun-Yin, Su, Hong-Lin, Tang, Chih-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956456/
https://www.ncbi.nlm.nih.gov/pubmed/24637722
http://dx.doi.org/10.1371/journal.pone.0090159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956456/
https://www.ncbi.nlm.nih.gov/pubmed/24637722
http://dx.doi.org/10.1371/journal.pone.0090159

Ejemplares similares